The expression levels of CASZ1a and CASZ1b in EOC specimens were increased by 10-fold relative to the benign pelvic mass group, although this elevation did not reach statistical significance (Figs. 6 b, c).
← all excerpts
ctDNA methylation profiling reveals NBL1 as a promising biomarker for early ovarian cancer screening.
1
—
—